Public Invited to Vote for Winner of Prestigious Annual
Award
OXFORD,
England, Aug. 7, 2024 /PRNewswire/ -- Amid
continuing focus on innovative treatments for heart disease, the
British Heart Foundation is inviting the public to vote for the
winner of the 2024 BHF Research Project of the Year,
recognising researchers and projects that have helped advance the
BHF's mission to fund life-saving research. The award highlights
the extraordinary BHF-funded research taking place around the UK
and how it has been brought to life for the public.
Caristo is proud to announce that the BHF-funded project that
led to the creation of the company and the development of the
CaRi-Heart® AI technology, is one of the three candidates for the
award.
The CaRi-Heart technology applies advanced AI algorithms
to routine heart coronary computed tomography angiogram (CCTA)
scans to visualise and quantify coronary inflammation, a key driver
of coronary artery disease and fatal heart attacks up to 10 years
in advance, helping to guide preventive treatment for at-risk
patients. This is the only technology in the world able to
accurately predict cardiac events by quantifying previously
invisible coronary artery inflammation. CaRi-Heart
technology supported a 40,000-patient research study, which was
recently published in The Lancet, demonstrating not only that it
accurately predicts future cardiac events but it also leads to
meaningful change in the management of nearly half the patients who
used it in the UK's NHS. This technology is now clinically
used by a growing list of hospitals in the UK, Europe and Australia.
Prof Antoniades, BHF Chair of Cardiovascular Medicine in the
University of Oxford and lead
investigator of the study, said: "I am thrilled to lead such
game-changing research, with true impact on clinical care. This
would have not been possible without the continuous support from
the BHF over the last decade."
Those interested in learning more about Prof. Antoniades' work
and that of the other award finalists can visit
https://www.bhf.org.uk/how-you-can-help/bhf-research-story-of-the-year to
cast their vote for the BHF Research Project of the Year
winner.
BBC Features CaRi-Heart Technology
On August 5, the BBC One program
South Today featured the use of CaRi-Heart technology
in five NHS Trust hospitals. The programme interviewed a
58-year-old man who was referred for a cardiac CT scan in
November 2023, after experiencing
persistent chest pain.
"It's a huge wake-up call," said Ian
Pickford, 58, from Barwell in Leicestershire, after CaRi-Heart
analysis suggested he was at risk of having a heart attack. Mr.
Pickford has now been prescribed statins, told to quit smoking and
exercise regularly.
About Caristo Diagnostics Limited
Caristo Diagnostics is a global leader in cardiac and
vascular disease diagnostics and risk prediction. Founded in 2018
as a spin-out company from the University of
Oxford, the world's #1 research university, Caristo has
developed a portfolio of imaging-based and AI-assisted platforms
that can be applied to aid the prediction and diagnosis of heart
attack, stroke, and diabetes. Caristo has been recognized by
Newsweek as one of the best digital health companies, and
highlighted by Nature as one of the most exciting science-based companies to have emerged
from academic labs. Find Caristo online on its website,
LinkedIn and X.
Logo:
https://mma.prnewswire.com/media/2054669/4848469/Caristo_Logo.jpg
View original content to download
multimedia:https://www.prnewswire.co.uk/news-releases/ai-that-detects-hidden-heart-disease-is-a-finalist-for-british-heart-foundations-research-project-of-the-year-award-302216628.html